Clinical Associate Professor of Medicine

E-Mail

Penn Presbyterian Medical Center
392 Wright-Saunders Building
39th & Market Streets
Philadelphia, PA 19104

Appointments
Contact: (215) 662-9189

Clinical Specialty:

• Cardiovascular Medicine

Practice Location:

• Penn Presbyterian Medical Center

Education:

• MD: Vanderbilt University
• Residency: Hospital of the University of Pennsylvania
• Fellowship: Hospital of the University of Pennsylvania

Research Interest:

• Cardiac catheterization
• Coronary angioplasty
• New anticoagulants in cardiology
• New devices for use in interventional cardiology
• Acute myocardial infarction and acute coronary syndromes

Selected Publications:

1. Jauch W., Kurnik P.B., Hanlon S.J., Siegel J. E., MATTHAI W.H. Expected Hemoglobin Decrease Following Balloon Angioplasty. Am J Cardiol 80:71-74, 1997.
2. Kussmaul W. G., Mishra J. P., MATTHAI, W. H., Hirshfeld, Jr. J. W. Complications of Cardiac Angiography Using Low or High Osmolality Contrast Agents in Patients with Left Main Coronary Stenosis. Cathet Cardiovasc Diagn 42:376-379, 1997.
3. Matthai WH Jr, Kurnik PB, Groh WC, Untereker WJ, Siegel JE. Antithrombin activity during the period of percutaneous coronary revascularizaton: relation to heparin use, thrombotic complications and restenosis. J Am Coll Cardiol, 33;1248-56, 1999.
4. Persin G, Matthai WH Jr. Catheter induced spasm of the left main coronary artery: a report of two cases and review of the literature. J Inv Cardiol, 12;158-61, 2000.
5. Klugherz BD, Meneveau NF, Kolansky DM, Herrmann HC, Schiele FC, Matthai WH, Groh WC, Untereker WJ, Hirshfeld JW, Bassand JL, Wilensky RL. Predictors of clinical outcome percutaneous intervention for in-stent restenosis. Am J Cardiol 85;1427-31, 2000.
6. Davidson CJ, Laskey WK, Hermiller JB, Harrison JK, Matthai WH, Bliestra RE, Brinker JA, Kereiakes DJ, Muhlestein JB, Popma J, Lansky A, Buchbinder M, Hirshfeld JW Jr. A randomized trial of contrast media utilization in high risk PTCA (The COURT Trial). Circulation, 101:2172-7, 2000.
7. Lewis BE, Wallis DE, Berkowitz SD, Matthai WH, Fareed J, Walenga JM, Bartholomew J, Sham R, Lerner RG, Zeigler ZR, Rutagi PK, Jang IK, Rifkin SD, Moran J, Hursting MJ, Kelton JG, for the ARG-911 Study Investigators. Argatroban Anticoagulant Therapy in Patients with Heparin-Induced Thrombocytopenia. Circulation 103:1838-43, 2001.
8. Kereiakes DJ, Grines C, Fry E, Esente P, Hoppensteadt D, Midei M, Barr L, Matthai W, Todd M, Broderick T, Rubinstein R, Fareed J, Santoian E, Neiderman A, Brodie B, Zidar J, Ferguson JJ, Cohen M. Enoxaparin and abciximab adjunctive pharmacotherapy during percutaneous coronary intervention. J Invas Cardiol 13:272-8, 2001.
9. Licata A, Matthai WH Jr. Evaluation of mechanical valve obstruction: use of clinical parameters, fluoroscopy, and echocardiography. Cathet Cardiovasc Intervent 55:495-500, 2002.
10. Lewis BE, Matthai WH, Cohen M, Moses, Hursting MJ, Leya F, for the ARG-216/310/311 Study Investigators. Argatroban anticoagulation during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia. Cathet Cardiovasc Intervent, 57:177-84, 2002.